Expression and function of Fas antigen in human oral epithelium.
Fas 抗原在人口腔上皮中的表达和功能。
基本信息
- 批准号:08672324
- 负责人:
- 金额:$ 1.22万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1996
- 资助国家:日本
- 起止时间:1996 至 1997
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The Fas antigen is a cell-surface glycoprotein that mediates apoptosis from the cell surface into the cytoplasm. A monospecific and high titer polyclonal antibody, designated as Fas D,was raised against synthetic polypeptides selected from a part of the human Fas antigen (amino acid resideues 104-114). This antibody was used to identify the Fas antigen in human oral epithelia in normal and pathological states. Biopsy specimens of normal human gingiva were prepared and the paraffin sections were reacted with the Fas D antibody by an immunohistochemical method. Specimens obtained from patients with odontogenic Keratocysts, leukoplakia, lichen planus, and squamous cell carcinoma were also stained with the antibody. The pattern of the Fas antigen distribution in oral stratified squamous epithelia was, with some overlapping, characteristic for each disease. The antibody localized to the prickle-cell layr and to granular layr of keratinocytes of human gingiva. Proteins were also prepared from human gingiva and subjected to SDS-PAGE,followed by Western blotting analysis with the Fas D antibody. The antibody interacted with a band cprresponding to an estimated molecular weight of 35 kDa. The incidence of the immunoreactive 35-kDa protein was detected in the gingiva of 90% of the 20 individuals examined. The localization of F as antigen in human oral squamous cell carcinoma also was examined. Out of 24 cases of the well-defferentiated tumors examined, 22 showed Fas-positive staining. Among the moderately differentiated tumors, four out of 11 cases showed Fas-positive staining. No Fas-positive cells were observed in the poorly differentiated tumors, but only three specimens were examined. The Fas antigen detected in human oral epithelia may be related to the physiological turnover of oral mucasa and pathological states in oral mucosa. The expression of Fas antigen also appears to be related to the degree of tumor differentiation.
Fas抗原是一种细胞表面糖蛋白,介导细胞凋亡从细胞表面进入细胞质。本文制备了一种单特异性高滴度的多克隆抗体,命名为Fas D,其抗人Fas抗原的一部分(氨基酸残基104-114)的合成多肽。用该抗体检测正常和病理状态下人口腔上皮细胞中Fas抗原的表达。制备正常人牙龈活检标本,石蜡切片用免疫组织化学方法与Fas D抗体反应。从牙源性角化囊肿、白斑、扁平苔藓和鳞状细胞癌患者中获得的标本也用抗体染色。Fas抗原在口腔复层鳞状上皮中的分布模式是每种疾病的特征,但有一些重叠。抗体定位于人牙龈角质形成细胞的棘细胞层和颗粒层。还从人牙龈制备蛋白质,并进行SDS-PAGE,然后用Fas D抗体进行蛋白质印迹分析。该抗体与一条对应于估计分子量为35 kDa的条带相互作用。免疫反应性35-kDa蛋白的发病率检测到90%的20个人检查的牙龈。并对F抗原在人口腔鳞状细胞癌中的定位进行了研究。在24例分化良好的肿瘤中,22例Fas阳性。在中分化肿瘤中,11例中有4例Fas阳性。在低分化肿瘤中未观察到Fas阳性细胞,但仅检查了3例标本。Fas抗原在口腔粘膜上皮细胞中的表达可能与口腔粘膜的生理更新和病理状态有关。Fas抗原表达与肿瘤分化程度有关。
项目成果
期刊论文数量(39)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
立石 晃: "耳下腺に発生したsalivary duct carcinomaの1例" 癌の臨床. 42. 579-582 (1996)
Akira Tateishi:“发生在腮腺的唾液管癌的病例”《癌症诊所》,42. 579-582 (1996)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
立石 晃: "口腔扁平上皮癌stageI,II手術施行例の臨床病理的検討" 日本口腔外科学会雑誌. 44. 11-15 (1998)
Akira Tateishi:“口腔鳞状细胞癌 I 期和 II 期手术病例的临床病理学研究”日本口腔颌面外科杂志 44. 11-15 (1998)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tateishi, A., Mise, K., Muraki, Y., Furuta, H., Yoshioka, I., Sogabe, K., yasumoto, S., and Fukuda, J.: "Clinicopathological study of stage I and II oral squamous cell carcinoma in patients undergoing surgical treatment." J.Oral Maxillofac.Surg.44. 11-15
Tateishi, A.、Mise, K.、Muraki, Y.、Furuta, H.、Yoshioka, I.、Sogabe, K.、yasumoto, S. 和 Fukuda, J.:“I 期和 II 期口腔的临床病理学研究
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Muraki,Y.: "Localization of Fas antigen in oral squamous cell carcinoma" British Jpurnal of Oral and Maxillofacial Surgery. (in press).
Muraki,Y.:“Fas 抗原在口腔鳞状细胞癌中的定位”英国口腔颌面外科杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Murata, T.: "Extracts of Prevotella intermedia and Actinobacillus Actino...inhibit alkaline phosphatase activity in osteoblastic cells..." Oral Deseases. 3. 106-112 (1997)
Murata, T.:“中间普雷沃氏菌和放线杆菌的提取物……抑制成骨细胞中的碱性磷酸酶活性……”口腔疾病。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FUKUDA Jinichi其他文献
FUKUDA Jinichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FUKUDA Jinichi', 18)}}的其他基金
Development of new anticancer drugs and nanobubbles suitable for specific molecular target therapy using sonoporation
利用声孔技术开发适合特定分子靶向治疗的新型抗癌药物和纳米气泡
- 批准号:
22390389 - 财政年份:2010
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identification of intracellular factors involved with apoptosis induction by TGF-β family
TGF-β家族诱导细胞凋亡相关细胞内因子的鉴定
- 批准号:
15390621 - 财政年份:2003
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Fas antigen and Fas ligand with Oral Disease
Fas抗原和Fas配体与口腔疾病
- 批准号:
10671900 - 财政年份:1998
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Fas Ligand Cleavage regulates ocular homeostasis and glaucoma
Fas 配体裂解调节眼稳态和青光眼
- 批准号:
10374484 - 财政年份:2022
- 资助金额:
$ 1.22万 - 项目类别:
Fas Ligand Cleavage regulates ocular homeostasis and glaucoma
Fas 配体裂解调节眼稳态和青光眼
- 批准号:
10867990 - 财政年份:2022
- 资助金额:
$ 1.22万 - 项目类别:
Fas Ligand Cleavage regulates ocular homeostasis and glaucoma
Fas 配体裂解调节眼稳态和青光眼
- 批准号:
10550147 - 财政年份:2022
- 资助金额:
$ 1.22万 - 项目类别:
Mechanisms of Fas Ligand Control of Insulitis in Autoimmune Diabetes
Fas配体控制自身免疫性糖尿病胰岛素炎的机制
- 批准号:
8811093 - 财政年份:2013
- 资助金额:
$ 1.22万 - 项目类别:
Mechanisms of Fas Ligand Control of Insulitis in Autoimmune Diabetes
Fas配体控制自身免疫性糖尿病胰岛素炎的机制
- 批准号:
8627108 - 财政年份:2013
- 资助金额:
$ 1.22万 - 项目类别:
Mechanisms of Fas Ligand Control of Insulitis in Autoimmune Diabetes
Fas配体控制自身免疫性糖尿病胰岛素炎的机制
- 批准号:
8504356 - 财政年份:2013
- 资助金额:
$ 1.22万 - 项目类别:
Mechanisms of Fas Ligand Control of Insulitis Initiation in Autoimmune Diabetes
Fas 配体控制自身免疫性糖尿病胰岛素炎发生的机制
- 批准号:
8440387 - 财政年份:2012
- 资助金额:
$ 1.22万 - 项目类别:
Provoking anti-tumor immune responses with Fas ligand
通过 Fas 配体激发抗肿瘤免疫反应
- 批准号:
7291653 - 财政年份:2006
- 资助金额:
$ 1.22万 - 项目类别:
Soluble Fas Ligand and Ocular Immune Privilege
可溶性 Fas 配体与眼部免疫特权
- 批准号:
7534765 - 财政年份:2004
- 资助金额:
$ 1.22万 - 项目类别:
Soluble Fas Ligand and Ocular Immune Privilege
可溶性 Fas 配体与眼部免疫特权
- 批准号:
7342074 - 财政年份:2004
- 资助金额:
$ 1.22万 - 项目类别: